This case illustrates a rare and unique case of a 73-year-old woman who presents with a
rapidly developing digital ischaemia, superior mesenteric artery thrombus with positive …

Introduction: Asherson's Syndrome, also defined as Catastrophic Antiphospholipid
Syndrome (CAPS), represents the most severe manifestation of Antiphospholipid Antibody …

Vascular surgery for chronic limb threatening ischemia (CLTI) in patients with
antiphospholipid syndrome (APS) has a poor outcome with a high rate of postoperative …

Antiphospholipid syndrome (APS) is an autoimmune disorder with characteristics of arterial
and/or venous thrombosis due to hypercoagulation status. Although deep vein thrombosis is …

Antiphospholipid syndrome (APS) is characterized by thrombosis (which may be venous,
arterial, or microvascular) and/or pregnancy morbidity in association with persistently …

Background: There is a paucity of studies on antiphospholipid syndrome (APS) in Asian
patients. Aim: This is the first study in Singapore to describe the clinical features, serological …

Introduction Antiphospholipid syndrome (APS) is a systemic autoimmune disease
characterized by recurrent thrombosis that can affect the arterial and venous circulation …

Objectives Patients with laboratory or clinical manifestations suggestive of antiphospholipid
syndrome (APS) but not fulfilling the classification criteria constitute a clinical challenge. This …

Background: Antiphospholipid syndrome (APS) is a prothrombotic condition defined by
arterial or venous thrombotic events and/or obstetrical morbidity in the presence of …

Antiphospholipid syndrome (APS) is recognized as one of the main determinants of
hypercoagulable conditions. The literature reports the incidence of this syndrome in a third …